Omotolani Olawunmi Akintunde
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Omotolani Olawunmi Akintunde has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Damilare Michael Akintunde
Ahmadu Bello University, Zaria, Nigeria
3 shared publications - Fatima Ishaq Abubakar
Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria
1 shared publication - Hadiza Kubra Ahmed
Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria
1 shared publication - Idrees Abiodun Rufai
Paediatrics, Usmanu Danfodiyo University, College of Health Sciences, Sokoto, Nigeria
1 shared publication - Michael Olaleye
Liverpool School of Tropical Medicine, UK
1 shared publication - Rosie Burton
Medecins Sans Frontieres, South Africa
1 shared publication
Latest Publications
- Open Access
- 14 August 2026
- Published by MDPI AG in Preprints.org
Antimicrobial Resistance in Noma Control: A Costly Neglect within Existing Neglect
Introduction: Noma is a severe gangrenous orofacial disease affecting malnourished children aged 2–6 years in extreme poverty, with 85–90% mortality if untreated. Recently classified as a Neglected Tropical Disease, it is managed mainly with empirical broad-spectrum antibiotics. Antimicrobial resistance (AMR) threatens to undermine treatment, yet AMR remains largely absent from Noma research and policy. This review examines AMR prevalence and drivers in Noma, identifies knowledge and policy gaps, and proposes recommendations.Methods: We reviewed literature on Noma microbiology and documented AMR, plus WHO NTD and AMR policy documents. Community and health system factors and surveillance capacity in Noma-endemic regions, primarily Sub-Saharan Africa, were synthesized.Results: Noma lesions show marked dysbiosis with frequent detection of Fusobacterium necrophorum, Prevotella spp., Staphylococcus aureus, Pseudomonas aeruginosa, and a novel “Treponema sp. A”. A 25-year retrospective analysis found that >92% of patients presented late, requiring prolonged antibiotics. Direct AMR data are scarce. Case reports documented MDR-Escherichia coli in Afghanistan(2012), Vancomycin-resistant Enterococci in South Korea(2022), ESBL E. coli in Mali(2021), Serratia marcescens (Ticarcilline, amoxicillin, and sulfamethoxazole-trimethoprim) and Pseudomonas aeruginosa (Rifampicin) in Chad (2014); and Pseudomonas aeruginosa (penicillins, carbapenems, aminoglycosides, sulfamethoxazole-trimethoprim, and nitrofurantoin) in Italy (2015). A recent metagenomic study reported high β-lactam and metronidazole resistance determinants, especially in Prevotella spp. Drivers include empirical broad-spectrum antibiotic use, self-medication, irrational prescribing, and weak diagnostics, with only a small share of laboratories across 14 SSA countries performing routine bacteriology and susceptibility testing. Policy gaps persist: WHO NTD and AMR strategies are siloed, anaerobes are excluded from GLASS surveillance, and Noma guidelines lack AMR triggers. Conclusion: AMR risks reversing gains in Noma control, and treatment centers may become AMR amplification sites without stewardship. Given limited microbiology data, we recommend adding AMR indicators to WHO and national Noma strategies, integrating anaerobic AMR surveillance at sentinel sites, generating Noma-specific antibiograms, and mandating antimicrobial stewardship in Noma programs. Mainstreaming AMR in Noma research and policy is essential to preserve therapeutic options.
- 14 August 2026
- Published by MDPI AG in Preprints.org
Open AccessAntimicrobial Resistance in Noma Control: A Costly Neglect within Existing Neglect
Introduction: Noma is a severe gangrenous orofacial disease affecting malnourished children aged 2–6 years in extreme poverty, with 85–90% mortality if untreated. Recently classified as a Neglected Tropical Disease, it is managed mainly with empirical broad-spectrum antibiotics. Antimicrobial resistance (AMR) threatens to undermine treatment, yet AMR remains largely absent from Noma research and policy. This review examines AMR prevalence and drivers in Noma, identifies knowledge and policy gaps, and proposes recommendations.Methods: We reviewed literature on Noma microbiology and documented AMR, plus WHO NTD and AMR policy documents. Community and health system factors and surveillance capacity in Noma-endemic regions, primarily Sub-Saharan Africa, were synthesized.Results: Noma lesions show marked dysbiosis with frequent detection of Fusobacterium necrophorum, Prevotella spp., Staphylococcus aureus, Pseudomonas aeruginosa, and a novel “Treponema sp. A”. A 25-year retrospective analysis found that >92% of patients presented late, requiring prolonged antibiotics. Direct AMR data are scarce. Case reports documented MDR-Escherichia coli in Afghanistan(2012), Vancomycin-resistant Enterococci in South Korea(2022), ESBL E. coli in Mali(2021), Serratia marcescens (Ticarcilline, amoxicillin, and sulfamethoxazole-trimethoprim) and Pseudomonas aeruginosa (Rifampicin) in Chad (2014); and Pseudomonas aeruginosa (penicillins, carbapenems, aminoglycosides, sulfamethoxazole-trimethoprim, and nitrofurantoin) in Italy (2015). A recent metagenomic study reported high β-lactam and metronidazole resistance determinants, especially in Prevotella spp. Drivers include empirical broad-spectrum antibiotic use, self-medication, irrational prescribing, and weak diagnostics, with only a small share of laboratories across 14 SSA countries performing routine bacteriology and susceptibility testing. Policy gaps persist: WHO NTD and AMR strategies are siloed, anaerobes are excluded from GLASS surveillance, and Noma guidelines lack AMR triggers. Conclusion: AMR risks reversing gains in Noma control, and treatment centers may become AMR amplification sites without stewardship. Given limited microbiology data, we recommend adding AMR indicators to WHO and national Noma strategies, integrating anaerobic AMR surveillance at sentinel sites, generating Noma-specific antibiograms, and mandating antimicrobial stewardship in Noma programs. Mainstreaming AMR in Noma research and policy is essential to preserve therapeutic options.
- Open Access
- 6 May 2026
- Published by MDPI AG in Preprints.org
Looming Threat of Overwhelming Multiple Disease Outbreaks in Sudan: A Call for Urgent Action
Sudan faces a looming threat of multiple overwhelming infectious disease outbreaks in 2026, driven primarily by conflict, displacement, and weakened health systems. Likely climate events, including floods, droughts, and heat waves, increase the likelihood and potential impact of outbreaks. Many epidemic-prone diseases have been identified by the WHO as health risks with high likelihood in the first third of 2026, including cholera, dengue fever, measles, acute enteric diseases (typhoid, rotavirus), acute respiratory tract infection, hepatitis E, meningococcal diseases, and Polio type 2; and classified as either very high risk or high risk based on the potential to cause morbidity/mortality. This is alongside other non-epidemic health crises such as malaria, malnutrition, and sexual and gender-based violence. There is an urgent need to strengthen key interventions, including the provision of safe water and sanitation and hygiene promotion for water-borne disease prevention and control, integrated vector surveillance and control for vector-borne diseases like dengue and malaria, and addressing low vaccination coverage through the re-establishment of routine immunizations and vaccination campaigns for diseases like diphtheria, pertussis, and meningitis. Strong community engagement (CE) remains central to preventing looming outbreak threats, alongside a commitment to coordination, funding, and implementation support for the Government of Sudan by UN agencies, including UNICEF and WHO, and humanitarian and development agencies, while ensuring localization. Collaborative efforts addressing vulnerabilities, healthcare preparedness, and community participation are required to limit the impact of the looming threat.
- 6 May 2026
- Published by MDPI AG in Preprints.org
Open AccessLooming Threat of Overwhelming Multiple Disease Outbreaks in Sudan: A Call for Urgent Action
Sudan faces a looming threat of multiple overwhelming infectious disease outbreaks in 2026, driven primarily by conflict, displacement, and weakened health systems. Likely climate events, including floods, droughts, and heat waves, increase the likelihood and potential impact of outbreaks. Many epidemic-prone diseases have been identified by the WHO as health risks with high likelihood in the first third of 2026, including cholera, dengue fever, measles, acute enteric diseases (typhoid, rotavirus), acute respiratory tract infection, hepatitis E, meningococcal diseases, and Polio type 2; and classified as either very high risk or high risk based on the potential to cause morbidity/mortality. This is alongside other non-epidemic health crises such as malaria, malnutrition, and sexual and gender-based violence. There is an urgent need to strengthen key interventions, including the provision of safe water and sanitation and hygiene promotion for water-borne disease prevention and control, integrated vector surveillance and control for vector-borne diseases like dengue and malaria, and addressing low vaccination coverage through the re-establishment of routine immunizations and vaccination campaigns for diseases like diphtheria, pertussis, and meningitis. Strong community engagement (CE) remains central to preventing looming outbreak threats, alongside a commitment to coordination, funding, and implementation support for the Government of Sudan by UN agencies, including UNICEF and WHO, and humanitarian and development agencies, while ensuring localization. Collaborative efforts addressing vulnerabilities, healthcare preparedness, and community participation are required to limit the impact of the looming threat.
- Open Access
- 9 April 2026
- Published by Oxford University Press (OUP) in Research Connections
- Vol. 1 (2)
Looming threat of overwhelming multiple disease outbreaks in Sudan: a call for urgent action
Sudan faces a looming threat of multiple overwhelming infectious disease outbreaks in 2026, driven primarily by conflict, displacement, and weakened health systems. Likely climate events, including floods, droughts, and heat waves, increase the likelihood and potential impact of outbreaks. Many epidemic-prone diseases have been identified by the WHO as health risks with high likelihood in the first third of 2026, including cholera, dengue fever, measles, acute enteric diseases (typhoid, rotavirus), acute respiratory tract infection, hepatitis E, meningococcal diseases, and Polio type 2; and classified as either very high risk or high risk b on the potential to cause morbidity/mortality. This is alongside other non-epidemic health crises such as malaria, malnutrition, and sexual and gender-based violence. There is an urgent need to strengthen key interventions, including the provision of safe water and sanitation and hygiene promotion for water-borne disease prevention and control, integrated vector surveillance and control for vector-borne diseases like dengue and malaria, and addressing low vaccination coverage through the re-establishment of routine immunizations and vaccination campaigns for diseases like diphtheria, pertussis, and meningitis. Strong community engagement remains central to preventing looming outbreak threats, alongside a commitment to coordination, funding, and implementation support for the government of Sudan by UN agencies, including UNICEF and WHO, and humanitarian and development agencies, while ensuring localization. Collaborative efforts addressing vulnerabilities, healthcare preparedness, and community participation are required to limit the impact of the looming threat.
- 9 April 2026
- Published by Oxford University Press (OUP) in Research Connections
- Vol. 1 (2)
Open AccessLooming threat of overwhelming multiple disease outbreaks in Sudan: a call for urgent action
Sudan faces a looming threat of multiple overwhelming infectious disease outbreaks in 2026, driven primarily by conflict, displacement, and weakened health systems. Likely climate events, including floods, droughts, and heat waves, increase the likelihood and potential impact of outbreaks. Many epidemic-prone diseases have been identified by the WHO as health risks with high likelihood in the first third of 2026, including cholera, dengue fever, measles, acute enteric diseases (typhoid, rotavirus), acute respiratory tract infection, hepatitis E, meningococcal diseases, and Polio type 2; and classified as either very high risk or high risk b on the potential to cause morbidity/mortality. This is alongside other non-epidemic health crises such as malaria, malnutrition, and sexual and gender-based violence. There is an urgent need to strengthen key interventions, including the provision of safe water and sanitation and hygiene promotion for water-borne disease prevention and control, integrated vector surveillance and control for vector-borne diseases like dengue and malaria, and addressing low vaccination coverage through the re-establishment of routine immunizations and vaccination campaigns for diseases like diphtheria, pertussis, and meningitis. Strong community engagement remains central to preventing looming outbreak threats, alongside a commitment to coordination, funding, and implementation support for the government of Sudan by UN agencies, including UNICEF and WHO, and humanitarian and development agencies, while ensuring localization. Collaborative efforts addressing vulnerabilities, healthcare preparedness, and community participation are required to limit the impact of the looming threat.
- Open Access
- 21 August 2025
- Published by BMJ in BMJ Paediatrics Open
- Vol. 9 (1) , e003468
Pattern and appropriateness of antibiotic therapy for acute respiratory tract infection among under-five children accessing care in a tertiary facility, Sokoto, Nigeria
Introduction: Acute respiratory tract infections (ARIs) are a major cause of antibiotic use among under-five (U5) children, often leading to inappropriate prescriptions that contribute to antimicrobial resistance, adverse drug reactions and higher healthcare costs. Objectives: To assess the pattern and rate of antibiotic prescriptions and evaluate their appropriateness based on WHO and Paediatric Association of Nigeria guidelines for ARI treatment among U5 children at Usmanu Danfodiyo University Teaching Hospital, Sokoto Methods: A retrospective review of medical records (case folders and prescription sheets) was conducted for U5 children diagnosed with ARI over a 10-month period at the paediatric outpatient and inpatient units, Department of Paediatrics, UDUTH. Data extracted included patient sociodemographic characteristics, ARI diagnosis based on Integrated Management of Childhood Illnesses/WHO criteria and antibiotic/medication details (class, name, route, dose, frequency, duration and regimen). Analysis was performed using SPSS V.20.0; p<0.05 was considered statistically significant. Results: A total of 2140 drugs and 1545 antibiotics were prescribed, averaging 2.2 and 1.6 per patient, respectively. Upper respiratory tract infections accounted for 66.2% of antibiotic indications. The antibiotic prescription rate was 100.0 %, with 71.0% administered parenterally. Most prescriptions used generic names (96.5%) and were listed in the National Essential Medicines List (100%). Cephalosporins were most frequently prescribed (46.4%), followed by penicillins; fluoroquinolones were least prescribed (1.2%). Mono-antibiotic therapy was used in 53.2% of cases. Notably, 81.5% of prescriptions came from second-line therapies. Appropriate prescribing was observed for duration (93.6%), dose (66.0%), frequency (69.7%) and indication/choice (66.5%). Conclusion: Despite encouraging adherence to appropriate antibiotic dosage regimen, the high rate of antibiotic prescription, parenteral antibiotic administration and alternative antibiotic use highlights ongoing concerns with risk of resistance, adverse effects and treatment failure. Strengthening antibiotic stewardship and adherence to first-line guidelines is crucial to optimise ARI treatment in resource-limited settings.
- 21 August 2025
- Published by BMJ in BMJ Paediatrics Open
- Vol. 9 (1) , e003468
Open AccessPattern and appropriateness of antibiotic therapy for acute respiratory tract infection among under-five children accessing care in a tertiary facility, Sokoto, Nigeria
Introduction: Acute respiratory tract infections (ARIs) are a major cause of antibiotic use among under-five (U5) children, often leading to inappropriate prescriptions that contribute to antimicrobial resistance, adverse drug reactions and higher healthcare costs. Objectives: To assess the pattern and rate of antibiotic prescriptions and evaluate their appropriateness based on WHO and Paediatric Association of Nigeria guidelines for ARI treatment among U5 children at Usmanu Danfodiyo University Teaching Hospital, Sokoto Methods: A retrospective review of medical records (case folders and prescription sheets) was conducted for U5 children diagnosed with ARI over a 10-month period at the paediatric outpatient and inpatient units, Department of Paediatrics, UDUTH. Data extracted included patient sociodemographic characteristics, ARI diagnosis based on Integrated Management of Childhood Illnesses/WHO criteria and antibiotic/medication details (class, name, route, dose, frequency, duration and regimen). Analysis was performed using SPSS V.20.0; p<0.05 was considered statistically significant. Results: A total of 2140 drugs and 1545 antibiotics were prescribed, averaging 2.2 and 1.6 per patient, respectively. Upper respiratory tract infections accounted for 66.2% of antibiotic indications. The antibiotic prescription rate was 100.0 %, with 71.0% administered parenterally. Most prescriptions used generic names (96.5%) and were listed in the National Essential Medicines List (100%). Cephalosporins were most frequently prescribed (46.4%), followed by penicillins; fluoroquinolones were least prescribed (1.2%). Mono-antibiotic therapy was used in 53.2% of cases. Notably, 81.5% of prescriptions came from second-line therapies. Appropriate prescribing was observed for duration (93.6%), dose (66.0%), frequency (69.7%) and indication/choice (66.5%). Conclusion: Despite encouraging adherence to appropriate antibiotic dosage regimen, the high rate of antibiotic prescription, parenteral antibiotic administration and alternative antibiotic use highlights ongoing concerns with risk of resistance, adverse effects and treatment failure. Strengthening antibiotic stewardship and adherence to first-line guidelines is crucial to optimise ARI treatment in resource-limited settings.